On June 11, 2026, the Centers for Disease Control and Prevention updated its official situation summary for the Andes hantavirus outbreak linked to the Dutch expedition cruise ship M/V Hondius — an event that began in the South Atlantic Ocean in late April, killed three people, and resulted in the most unusual federal quarantine activation on U.S. soil in years. The update confirmed that 10 of the 18 Americans repatriated to the Nebraska Quarantine Unit at the University of Nebraska Medical Center remain under active monitoring there, while 8 others have met the criteria to complete their 42-day monitoring period from home. Separately, passengers who had already disembarked the ship and returned to the U.S. before the outbreak was formally identified completed their own 42-day monitoring period on June 6 with no detected hantavirus cases.
The update is being followed closely by global health officials, infectious disease specialists, and cruise industry safety advocates, because this cluster represented something unprecedented: a multi-country outbreak of Andes virus linked to a single commercial vessel, involving citizens from 23 different countries and exposures that occurred at some of the most remote locations on Earth.
How the Outbreak Began — and Why It Spread
The M/V Hondius, a Dutch-flagged expedition cruise vessel operated by Oceanwide Expeditions, departed from Ushuaia, Argentina, on April 1, 2026, carrying 147 people: 86 passengers and 61 crew members. The ship's itinerary took it to Antarctica, South Georgia Island, Tristan da Cunha, Saint Helena, and Ascension Island — remote wildlife-rich locations that are among the most ecologically pristine places on the planet, but also places where Andes virus-carrying rodents are known to exist.
Several passengers developed what appeared to be flu-like symptoms in early April. Among them was Dr. Stephen Kornfeld, an American oncologist who was serving as a volunteer medical officer aboard the ship. He later described to CNN the haunting experience of watching patients deteriorate while at sea, with no clear diagnosis and no way to identify the pathogen causing the illness. Two people died aboard or shortly after disembarking, and laboratory testing conducted in South Africa on May 2 confirmed that Andes hantavirus — the only hantavirus known to be capable of human-to-human transmission — was responsible.
By May 6, the World Health Organization had confirmed the Andes virus identification and the CDC deployed a rapid response team to meet the ship in the Canary Islands. As the ship docked, international quarantine coordination began, with passengers from 23 countries routed to their respective home countries for monitoring. In the United States, the State Department issued health guidance, and the CDC arranged for 18 Americans to be flown to Nebraska — the site of the National Quarantine Unit, the most specialized biocontainment and public health monitoring facility in the country.
What the 42-Day Quarantine Means
The 42-day monitoring period chosen for the M/V Hondius passengers is not arbitrary. It is based on the outer edge of the known incubation period for Andes hantavirus, which typically ranges from 9 to 33 days but can in rare cases extend further. Rather than defaulting to the shorter standard 21-day Ebola quarantine timeline, CDC opted for 42 days to maximize certainty — a decision that reflects the evolving understanding of Andes virus biology and the particularly severe nature of its pulmonary syndrome.
Hantavirus pulmonary syndrome (HPS) caused by Andes virus begins with a prodromal phase indistinguishable from flu: fever, fatigue, muscle aches, and headache. It then progresses, in severe cases, to a cardiopulmonary phase characterized by rapidly worsening shortness of breath, filling of the lungs with fluid, and life-threatening circulatory collapse. The case fatality rate for HPS caused by North American hantaviruses (which do not spread person to person) is approximately 38 percent; Andes virus-specific mortality data from the current outbreak are still being analyzed.
There are no FDA-approved antiviral treatments for Andes hantavirus. Management consists entirely of intensive supportive care — oxygen supplementation, mechanical ventilation, fluid management, and in the most severe cases, extracorporeal membrane oxygenation (ECMO). This absence of specific treatment makes early recognition and clinical vigilance the most important tools available.
The Washington State Connection and Ongoing Domestic Risk
While the M/V Hondius cluster remains the primary public health focus, a reminder of domestic hantavirus risk emerged when the Washington State Department of Health reported a separate hantavirus case in the state unrelated to the cruise ship. This individual was infected after exposure to rodents — the standard transmission route for the many North American hantavirus strains that do not spread person to person. The Washington patient was infected with a strain that does not transmit between humans, and no public health follow-up for contacts was required.
This case is a useful reminder that while Andes hantavirus generates international attention because of its person-to-person transmission potential, dozens of hantavirus cases occur in the United States every year through ordinary rodent exposures. Sin Nombre virus, the most common cause of HPS in North America, is transmitted primarily through inhalation of aerosolized rodent urine, droppings, or nesting material. People who spend time in cabins, barns, or other structures where rodents may nest, campers, hikers, farmworkers, and anyone engaged in activities that disturb rodent habitats all face elevated exposure risk.
What Travelers Should Know
The CDC has assessed the risk to the American public from the M/V Hondius cluster as extremely low. No confirmed cases of Andes hantavirus have been identified among U.S. residents. Expedition cruise travelers visiting South America or remote island locations should be aware of the possibility of rodent exposure at wildlife-rich sites and practice standard rodent avoidance: do not handle rodents or their nests, do not disturb nesting materials, and use insect repellent in areas with known rodent activity.
Anyone who develops fever, severe fatigue, or respiratory symptoms within 42 days of travel to South America — or following close contact with anyone who was aboard the M/V Hondius — should seek medical care promptly and disclose their travel history.
Frequently Asked Questions
Q: Where do things stand with the M/V Hondius hantavirus outbreak as of June 11, 2026?
A: 10 Americans remain at the Nebraska Quarantine Unit, 8 have been cleared to complete monitoring at home. Passengers who returned to the US before the outbreak was identified completed their 42-day monitoring period June 6 with no detected cases. The global cluster included 11 confirmed and probable cases and 3 deaths.
Q: Why was Andes hantavirus so concerning compared to other hantavirus strains?
A: Andes virus is the only hantavirus known to spread between humans through close, prolonged contact. All other hantaviruses spread exclusively through rodent exposure. This made the cruise ship cluster uniquely alarming from a public health containment standpoint.
Q: Is there a treatment for hantavirus pulmonary syndrome?
A: There is no FDA-approved antiviral treatment. Management is entirely supportive — intensive care, mechanical ventilation, and, in severe cases, ECMO. Early recognition is critical because deterioration can be rapid.
Q: How long is the incubation period for Andes hantavirus?
A: Typically 9 to 33 days, though the CDC applied a conservative 42-day monitoring window for the M/V Hondius passengers to account for potential outliers.
Q: What is the risk to Americans who were not on the cruise ship?
A: The CDC assesses the overall risk to the American public as extremely low. No person-to-person transmission has been detected beyond close contact with confirmed cases. Andes virus does not spread like a respiratory virus.
